Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 47.90
+0.90 (1.91%)
Dec 5, 2025, 9:00 AM CET
Clínica Baviera Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 40.48 | 40.21 | 35.97 | 29.52 | 27.39 | 13.94 | Upgrade |
Depreciation & Amortization | 22.55 | 19.98 | 16.46 | 14.8 | 13.89 | 13.38 | Upgrade |
Other Amortization | 0.9 | 0.9 | 0.52 | 0.2 | 0.2 | 0.16 | Upgrade |
Asset Writedown & Restructuring Costs | -0.03 | -0.03 | 0.03 | 0.47 | 0.03 | - | Upgrade |
Provision & Write-off of Bad Debts | 0.06 | 0.06 | -0.02 | 0.18 | 0.06 | 0.01 | Upgrade |
Other Operating Activities | 4.94 | 3.19 | 3.09 | 3.25 | 1.44 | 1.56 | Upgrade |
Change in Accounts Receivable | 0.22 | 0.22 | -0.43 | 0.18 | -0.91 | 0.56 | Upgrade |
Change in Inventory | -0.25 | -0.25 | -0.31 | -0.23 | -0.29 | -0.44 | Upgrade |
Change in Accounts Payable | -1.78 | -1.78 | 2.5 | 5.02 | 5.04 | 2.29 | Upgrade |
Operating Cash Flow | 72.09 | 62.51 | 57.81 | 53.38 | 46.86 | 31.46 | Upgrade |
Operating Cash Flow Growth | 14.37% | 8.12% | 8.31% | 13.92% | 48.96% | 23.83% | Upgrade |
Capital Expenditures | -25.69 | -26.51 | -22.68 | -14.03 | -10.58 | -7.82 | Upgrade |
Cash Acquisitions | -0.92 | -11.11 | - | - | -0.05 | - | Upgrade |
Investment in Securities | 16.42 | 16.42 | -21.79 | 1.4 | -6.46 | -13.59 | Upgrade |
Other Investing Activities | -0.68 | 0.3 | 0.15 | 0.07 | 0 | 0.01 | Upgrade |
Investing Cash Flow | -10.87 | -20.9 | -44.31 | -12.56 | -17.08 | -21.4 | Upgrade |
Long-Term Debt Issued | - | 7.2 | - | - | 0.08 | 10.04 | Upgrade |
Long-Term Debt Repaid | - | -11.79 | -10.52 | -13.69 | -13.43 | -12.93 | Upgrade |
Net Debt Issued (Repaid) | -9.8 | -4.59 | -10.52 | -13.69 | -13.35 | -2.89 | Upgrade |
Issuance of Common Stock | 1.43 | 1.43 | 0.71 | 0.6 | 0.5 | 0.2 | Upgrade |
Repurchase of Common Stock | -10.24 | -10.24 | -0.71 | -0.62 | -0.49 | -0.19 | Upgrade |
Common Dividends Paid | -25.56 | -25.09 | -13.04 | -16.79 | -17.15 | - | Upgrade |
Other Financing Activities | 8.28 | -1.17 | -0.81 | -0.95 | -0.31 | -0.27 | Upgrade |
Financing Cash Flow | -35.9 | -39.66 | -24.37 | -31.45 | -30.8 | -3.15 | Upgrade |
Foreign Exchange Rate Adjustments | 0.12 | -0.12 | - | - | - | - | Upgrade |
Net Cash Flow | 25.44 | 1.83 | -10.87 | 9.37 | -1.02 | 6.9 | Upgrade |
Free Cash Flow | 46.4 | 36 | 35.13 | 39.35 | 36.28 | 23.64 | Upgrade |
Free Cash Flow Growth | 27.57% | 2.46% | -10.71% | 8.45% | 53.50% | 45.81% | Upgrade |
Free Cash Flow Margin | 15.63% | 13.55% | 15.47% | 19.83% | 20.94% | 19.28% | Upgrade |
Free Cash Flow Per Share | 2.90 | 2.25 | 2.15 | 2.41 | 2.23 | 1.45 | Upgrade |
Cash Interest Paid | 0.18 | 0.18 | 0.11 | 0.46 | 0.11 | 0.12 | Upgrade |
Cash Income Tax Paid | 15.34 | 13.08 | 11.64 | 9.63 | 11.28 | 4.36 | Upgrade |
Levered Free Cash Flow | 35.54 | 30.98 | 26.81 | 33.33 | 31.68 | 21.5 | Upgrade |
Unlevered Free Cash Flow | 37.31 | 31.74 | 27.16 | 33.59 | 31.96 | 21.84 | Upgrade |
Change in Working Capital | 3.18 | -1.81 | 1.76 | 4.96 | 3.84 | 2.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.